# Rapid Medical, Ltd.

- Location (FDA's records): Yokneam, IL
- FDA decisions: 12 (2019–2026): 10 510(k) clearances and 2 De Novo grants
- Names in FDA's records: Rapid Medical , Ltd. (6); Rapid-Medical , Ltd. (4); Rapid Medical Ltd. (2)
- Product codes: NRY (6), MOF (3), QZU (1), PUU (1), DQX (1)
- 510(k) review time since 2016: median 171 days, against 129 for FDA's reviews in the same codes and years (1 of 9 faster)
- Predicates its devices cite: 11 (7 its own); citations of its devices by later devices: 7 (7 its own)
- Recalls linked to its devices: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms whose devices it cites most
- Scientia Vascular, LLC: 1 (https://510kreport.com/company/scientia-vascular)
- Micro Therapeutics, Inc. d/b/a ev3 Neurovascular: 1 (https://510kreport.com/company/micro-therapeutics-d-b-a-ev3-neurovascular)
- MicroVention, Inc.: 1 (https://510kreport.com/company/microvention)
- Ashitaka Factory of Terumo Corp.: 1 (https://510kreport.com/company/ashitaka-factory-of-terumo)

## Its most-cited devices
- K203592: Tigertriever and Tigertriever 17 Revascularization Devce (2021), cited by 4
- K220808: Tigertriever 13 Revascularization Device (2022), cited by 2
- K233791: Drivewire 24 Guidewire (2024), cited by 1

## Recent decisions
- K253146: Hyperdrive 35 Guidewire (Sep 18, 2026)
- K260617: Tigertriever 13 Ultra Revascularization Device (Aug 28, 2026)
- K254006: Drivewire 35 Guidewire (Jul 17, 2026)
- K253062: Tigertriever 25 Revascularization Device (Mar 12, 2026)
- K251603: Tigertriever 17 Ultra Revascularization Device (Oct 6, 2025)
- K233791: Drivewire 24 Guidewire (Jul 11, 2024)
- DEN230064: BraidE Embolization Assist Device (Feb 21, 2024)
- K230429: Tigertriever 21 Revascularization Device, Tigertriever 17 Revascularization Device, Tigertriever 13 Revascularization Device (Apr 17, 2023)

Source page: https://510kreport.com/company/rapid-medical